期刊
JOURNAL OF GENETICS AND GENOMICS
卷 48, 期 6, 页码 444-451出版社
SCIENCE PRESS
DOI: 10.1016/j.jgg.2021.04.003
关键词
MAD7 nuclease; CRISPR-Cas12a; Plant genome editing; Royalty-free; Commercial use
资金
- Strategic Priority Research Program of the Chinese Academy of Sciences [XDA24020101, XDA24020310]
- National Natural Science Foundation of China [31672015, 31788103]
- Youth Innovation Promotion Association of the Chinese Academy of Sciences [2020000003]
MAD7 is a novel CRISPR-Cas nuclease that can be used for plant genome editing, recognizing T-rich PAM sequences. By developing variants and additional systems, the targeting range and editing efficiency of MAD7 can be enhanced, and it performs well in multiplex gene editing.
MAD7 is an engineered nuclease of the Class 2 type V-A CRISPR-Cas (Cas12a/Cpf1) family with a low level of homology to canonical Cas12a nucleases. It has been publicly released as a royalty-free nuclease for both academic and commercial use. Here, we demonstrate that the CRISPR-MAD7 system can be used for genome editing and recognizes T-rich PAM sequences (YTTN) in plants. Its editing efficiency in rice and wheat is comparable to that of the widely used CRISPR-LbCas12a system. We develop two variants, MAD7-RR and MAD7-RVR that increase the target range of MAD7, as well as an M-AFID (a MAD7-APOBEC fusion-induced deletion) system that creates predictable deletions from 50 -deaminated Cs to the MAD7-cleavage site. Moreover, we show that MAD7 can be used for multiplex gene editing and that it is effective in generating indels when combined with other CRISPR RNA orthologs. Using the CRISPR-MAD7 system, we have obtained regenerated mutant rice and wheat plants with up to 65.6% efficiency. Copyright (C) 2021, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据